In this article, Andrew Toher, Head of Customer Insights Europe at Enel X, delves into the potential benefits and key considerations of a sustainable energy strategy.
The pharmaceutical sector is not typically seen as a highly polluting, ‘heavy industry’ but it is far from green. In its 2021 report Delivering a ‘Net Zero’ National Health Service, the UK’s NHS attributes as much as a quarter of its carbon footprint to medicines. A deep carbon footprint is a common hallmark of energy intensive manufacturing processes – and the manufacture of pharmaceuticals is no exception. However, emissions levels can be reduced by adopting a sustainable approach to process efficiency, energy generation and energy procurement.
This webinar showcases the Growth Direct System; an RMM (Rapid Microbial Method) that improves on traditional membrane filtration, delivering increased accuracy, a faster time to result, enhanced data integrity compliance, and more control over the manufacturing process.
Key learning points:
Understand the benefits of full workflow microbiology quality control testing automation in radiopharmaceutical production
Learn about ITM’s implementation journey and considerations when evaluating the technology
Find out how the advanced optics and microcolony detection capabilities of Growth Direct® technology impact time to result (TTR).
Don’t miss your chance to learn from experts in the industry –Register for FREE
Can’t attend live? No worries – register to receive the recording post-event.
In addition to the environmental benefits of reducing carbon emissions, a sustainable energy strategy has financial implications too. Increasingly volatile energy costs and punitive carbon taxes have a tangible impact on profitability. On 1 January 2021, a UK Emissions Trading Scheme (UK ETS) replaced the UK’s participation in the European Union (EU) ETS. The four governments of the UK established the scheme to increase the climate ambition of the UK’s carbon pricing policy, whilst also protecting the competitiveness of UK businesses. As a result, large carbon emitters have experienced dramatic increases in compliance costs in recent times.
There is also a reputational imperative to act on carbon emissions. As an industry comprising some of the world’s most trusted brands, it has a corporate social responsibility to “do the right thing”. Key stakeholders, including investors, want to see positive action on carbon emissions as part of a comprehensive environmental and social governance policy. For many pharmaceutical companies, with complex, multinational operations, the challenge is devising a net-zero roadmap that is both effective and sustainable.
Formulating a sustainable energy strategy
Deep carbon footprints are a common hallmark of energy intensive manufacturing processes including pharmaceuticals.
Figuring out where to start on the road to sustainability can be daunting. Considering energy strategy alongside corporate sustainability goals is key to delivering a comprehensive, strategic roadmap with impact.
The first step is to gather and analyse data to build foundations for the strategy and create a benchmark to measure action against. Calculating the emissions inventory, including operational and indirect emissions, is possible with the right software and systems in place. To capture the environmental benefits of sustainability programmes, carbon reporting should be an integral part of any software solution. This allows organisations to track data associated with the purchase, consumption and generation of energy including its impact on sustainability goals and environmental benefits using market and location-based emission calculations.
Voluntarily reporting emissions through a globally recognised framework demonstrates a commitment to sustainability. A carbon disclosure rating or “CDP score” is a measurement of the environmental sustainability of a corporation. CDP scores are visible through several investor platforms and, alongside other initiatives such as RE100 for businesses committing to use 100 percent renewable energy, they will help to drive change across an organisation while also signalling intent to shareholders.
Independently run workshops can be a powerful way to support the development of a decarbonisation roadmap for any organisation, enabling information to be shared and improving levels of understanding about energy efficiency, generation and procurement.
The outcome should be a strategic plan that maps out energy strategies to support the business’s sustainability goals.
Actions can include optimising behind-the-meter assets, procuring renewable energy through power purchase agreements (PPAs), and participating in capacity, ancillary and energy market programmes to optimise energy use and support the electricity grid to manage increasing levels of renewable energy. Having a detailed picture of energy use will highlight which areas to prioritise to improve efficiency and reduce emissions.
Resiliency and renewables
With a comprehensive energy strategy, pharmaceutical businesses can reduce carbon emissions, maintain resilience, predict future energy costs and enhance ESG performance”
Going green is not without its challenges. As the global demand for energy increases, industrial and commercial energy users are increasingly concerned with security of supply and the reliability of out-dated grid infrastructure. As we reduce our dependence on fossil fuels for energy generation and shift to renewables such as solar and wind, the intermittent nature of these sources of power can disrupt the balance of supply and demand needed to maintain grid stability. Large energy users such as pharmaceutical manufacturers can play an important role in protecting grid stability while enabling more renewable generation.
Participation in energy flexibility programmes, such as demand response (DR), supports the electricity grid operator to handle increasing amounts of energy from renewable sources. At times of peak electricity demand, or reduced levels of production from renewable sources, an energy intensive facility that can temporarily adjust its overall consumption can receive significant payments without impacting on business operations. Additionally, DR can act as an early warning of grid problems and provides realistic opportunities to test standby power systems.
Procuring low-carbon energy
Procuring renewable contracts successfully is a complex task. A typical requirement is to make a long-term power purchase agreement (PPA) with an energy company that can guarantee to supply clean electricity sufficient to meet an organisation’s growing needs.
The NHS attributes as much as a quarter of its carbon footprint to medicines.
Like other energy-intensive businesses, pharmaceutical companies are choosing to become off-takers, using PPAs to buy renewable energy and to complement the use of on-site generation. This increases the percentage of renewable energy utilised, thus reducing emissions. This approach guarantees supply, allows companies to reliably predict future costs and signals a long-term commitment to zero carbon.
Negotiating PPAs can be technically complex, requiring a depth of knowledge and experience to deliver a bespoke agreement that suits both generator or supplier and off-taker.
Conclusions
With a comprehensive energy strategy, pharmaceutical businesses can reduce carbon emissions, maintain resilience, predict future energy costs and enhance environmental, social and corporate governance (ESG) performance. An effective strategy must include optimising energy use, planning and implementing a procurement strategy, and exploring ways to co-operate with energy companies and grid operators. By adopting a sustainable energy strategy, pharmaceutical manufacturers can reduce carbon emissions, help maintain the stability of the grid and create valuable sources of new income.
About the author
Andrew Toher is Head of Customer Insights Europe at Enel X.
This is an incredibly timely and important discussion. The pharmaceutical industry plays a critical role in global healthcare, but its energy consumption and environmental impact are undeniable. Developing sustainable energy strategies tailored to pharmaceutical manufacturing is a win-win scenario. By embracing renewable energy sources, optimizing production processes, and implementing energy-efficient technologies, manufacturers can not only reduce their carbon footprint but also cut operational costs in the long run. It’s encouraging to see the industry addressing these challenges head-on and recognizing the need for innovation and responsible practices. Collaboration between pharmaceutical companies, regulatory bodies, and sustainability experts will be pivotal in driving these strategies forward. As we prioritize both public health and the health of our planet, these initiatives are a crucial step towards a greener and healthier future.
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.
This is an incredibly timely and important discussion. The pharmaceutical industry plays a critical role in global healthcare, but its energy consumption and environmental impact are undeniable. Developing sustainable energy strategies tailored to pharmaceutical manufacturing is a win-win scenario. By embracing renewable energy sources, optimizing production processes, and implementing energy-efficient technologies, manufacturers can not only reduce their carbon footprint but also cut operational costs in the long run. It’s encouraging to see the industry addressing these challenges head-on and recognizing the need for innovation and responsible practices. Collaboration between pharmaceutical companies, regulatory bodies, and sustainability experts will be pivotal in driving these strategies forward. As we prioritize both public health and the health of our planet, these initiatives are a crucial step towards a greener and healthier future.